Description
Somatropin for Injection USP is a sterile, lyophilized preparation containing recombinant human growth hormone (rhGH) produced through recombinant DNA (rDNA) technology. Somatropin is structurally identical to endogenous human growth hormone and exhibits growth-promoting and metabolic effects. The product is manufactured in compliance with USP standards and is intended for subcutaneous administration after reconstitution.
